278
Views
53
CrossRef citations to date
0
Altmetric
Original Article

Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease

, , , , &
Pages 219-224 | Received 09 Jun 2008, Accepted 01 Sep 2008, Published online: 08 Jul 2009

References

  • National Heart, Lung, and Blood Institute. Morbidity and mortality: chartbook on cardiovascular, lung, and blood diseases. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health; 1998., Bethesda, MD 1998, Available at: www.nhlbi.nih.gov/nhlbi/seiin/other/cht‐book/htm (accessed 20.12.07)
  • Pinto‐Plata V. M., Mullerova H., Toso J. F., Feudjo‐Tepie M., Soriano J. B., Vessey R. S., et al. C‐reactive protein in patients with COPD, control smokers and non‐smokers. Thorax 2006; 61: 23–8
  • Çalıkoğlu M., Tamer L., Çalıkoğlu I., Atış S., Ulubaş B., Ercan B. Oxidative stress and products of nitric oxide metabolism in chronic obstructive pulmonary disease and in healthy smokers. Turk Respir J 2002; 3: 24–7
  • Sin D. D., Man S. F. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003; 107: 1514–9
  • Wouters E., Groenewegen K., Dentener M., Vernooy J. H. Systemic inflammation in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2007; 4: 626–34
  • Pasceri V., Willerson J. T., Yeh E. T. Direct proinflammatory effect of C‐reactive protein on human endothelial cells. Circulation 2000; 102: 2165–8
  • Desruisseaux M. S., Nagajyothi, Trujillo M. E., Tanowitz H. B., Schere P. E. Adipocyte, adipose tissue, and infectious disease. Infect Immun 2007; 75: 1066–78
  • Lago F., Dieguez C., Gómez‐Reino J., Gualillo O. Adipokines as emerging mediators of immune response and inflammation. Nat Clin Pract Rheumatol 2007; 3: 716–24
  • Anthonisen N. R., Connett J. E., Enright P. L., Manfreda J. Lung Health Study Research Group. Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med 2002; 166: 333–9
  • De Torres J. P., Cordoba‐Lanus E., Lopez‐Aguilar C., Muros de Fuentes M., Montejo de Garcini A., Aguirre‐Jaime A., et al. C‐reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J 2006; 27: 902–7
  • Gan W. Q., Man S. F., Senthilselvan A., Sin D. D. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta‐analysis. Thorax 2004; 59: 574–80
  • Schneider A., Dinant G. J., Maag I., Gantner L., Meyer J. F., Szecsenyi J. The added value of C‐reactive protein to clinical signs and symptoms in patients with obstructive airway disease: results of a diagnostic study in primary care. BMC Fam Pract 2006; 7: 28
  • Pepys M. B. C‐reactive protein fifty years on. Lancet 1981; 1: 653–7
  • Ricciardolo F. L., Di Stefano A., Sabatini F., Folkerts G. Reactive nitrogen species in the respiratory tract. Eur J Pharmacol 2006; 533: 240–52
  • Agusti A. G., Villaverde J. M., Togores B., Bosch M. Serial measurements of exhaled nitric oxide during exacerbations of chronic obstructive pulmonary disease. Eur Respir J 1999; 4: 523–8
  • Kharitonov S. A., Barnes P. J. Nitric oxide, nitrotyrosine, and nitric oxide modulators in asthma and chronic obstructive pulmonary disease. Curr Allergy Asthma Rep 2003; 3: 121–9
  • Ingelsson E., Ärnlöv J., Sundström Lind L. Inflammation, as measured by the erythrocyte sedimentation rate, is an independent predictor for the development of heart failure. J Am Coll Cardiol 2005; 45: 1802–6
  • NHLBI/WHO Global initiative for chronic obstructive lung disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive lung disease (updated 2006). Available at: http://www.goldcopd.com (accessed 20.12.07)
  • ATS/ERS Task Force: Standardization of lung function testing. Eur Respir J 2005; 26: 319–38
  • Bestall J. C., Paul E. A., Garrod R. Usefulness of the Medical Research Council (MRC) dyspnea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: 581–6
  • Mahler D. A., Weinberg D. H., Wells C. K., Feinstein A. R. The measurement of dyspnea. Chest 1984; 85: 751–8
  • Tsuda H., Takata T., Nagafuchi S., Etoh F., Kurihara M., Hattori S., et al. Falsely increased nephelometric results caused by a monoclonal rheumatoid factor. Clin Chem 1990; 36: 1263–4
  • Navarro‐Gonzalves J. A., Garcia‐Benayes C., Arenas J. Semiautomated measurement of nitrate in biological fluids. Clin Chem 1998; 44: 679–81
  • Tomoda K., Yoshikawa M., Itoh T., Tamaki S., Fukuoka A., Komeda K., et al. Elevated circulating plasma adiponectin in underweight patients with COPD. Chest 2007; 132: 135–40
  • Donahoe M., Rogers R. M., Wilson D. O., Pennock B. E. Oxygen consumption of the respiratory muscles in normal and in malnourished patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1989; 140: 385–91
  • Bluher M., Bullen J. W Jr., Lee J. H., Kralisch S., Fasshauer M., Klöting N., et al. Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training. J Clin Endocrinol Metab 2006; 91: 2310–16
  • Zeng Q., Isobe K., Fu L., Ohkoshi N., Ohmori H., Takekoshi K., et al. Effects of exercise on adiponectin and adiponectin receptor levels in rats. Life Sci 2007; 80: 454–9
  • Yang M., Sun T. Y., Liu X. M. The role of serum leptin and tumor necrosis factor‐alpha in malnutrition of male chronic obstructive pulmonary disease patients. Chin Med J 2006; 119: 628–33
  • Karakas S., Karadag F., Karul A. B., Gurgey O., Gurel S., Guney E., et al. Circulating leptin and body composition in chronic obstructive pulmonary disease. Int J Clin Pract 2005; 59: 1167–70
  • Yuan Y., Wang Z., Liu C. Preliminary investigation of effect of serum leptin on nutritional state of COPD patients. Zhonghua Jie He He Hu Xi Za Zhi 2000; 23: 292–5
  • Karadag F., Kirdar S., Karul A. B., Ceylan E. The value of C‐reaktif protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease. Eur J Intern Med 2008; 19: 104–8
  • Wu S. J., Chen P., Jiang X. N., Liu Z. J. C‐reactive protein level and the correlation between lung function and CRP levels in patients with chronic obstructive pulmonary diseases. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2005; 30: 444–6
  • Karadag F., Karul A. B., Cildag O. Biomarkers of systemic inflammation in stable and exacerbation phases of COPD. Lung. 2008, doi: 10.1007/s00408‐008‐9106‐6
  • Tsoumakidou M., Tzanakis N., Chrysofakis, Siafakas N. M. Nitrosative stress, heme oxygenase‐1 expression and airway inflammation during severe exacerbations of COPD. Chest 2005; 127: 1911–18
  • Rutgers S. R., Van der Mark T. W., Coers W., Moshage H., Timens W., Kauffman H. F., et al. Markers of nitric oxide metabolism in sputum and exhaled air are not increased in chronic obstructive pulmonary diseases. Thorax 1999; 54: 576–80

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.